Rasmus Hoeg, M.D.

Rasmus Tetens Hoeg, M.D.


Bone Marrow Transplant


Internal Medicine


  • Assistant Professor (HSCP)


To see if Rasmus Tetens Hoeg is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

UC Davis Comprehensive Cancer Center

2279 45th Street
Sacramento, CA 95817
Driving Directions

Primary Phone:

Additional Phone Numbers

Clinic Phone: 916-734-5981
Clinic Fax: 916-734-0631
Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Philosophy of Care

Dr. Hoeg believes in high quality, innovative, and compassionate care of his patients. Dr. Hoeg believes in a team-based approach to patient care, utilizing expertise of nurses, pharmacists, social workers, and consultants to provide complete care for his patients.

Clinical Interests

Dr. Hoegs’ clinical interests include: Bone Marrow Transplant and other hematologic malignancies.

Research/Academic Interests

Dr. Hoeg's research interest is in Infectious Disease of Bone Marrow Transplant.


Hematology and Oncology

Center/Program Affiliation

UC Davis Comprehensive Cancer Center


M.D., University of Copenhagen, Copenhaven, Denmark 2005

B.A., University of Copenhagen, Copenhagen, Denmark 1998


Internal Medicine, Gundersen Lutheran Medical Foundation, La Crosse WI 2008


Hematology, Herlev Hospital, Herlev, Denmark 2010-2011

Hematology/Oncology, N�stved Sygehus, N�stved, Denmark 2009-2010

Hematology/Oncology, N�stved Sygehus, N�stved, Denmark 2012-2013

Board Certifications

American Board of Internal Medicine- Diplomat, Hematology/Oncology,

California Medical License,

Professional Memberships

American College of Physicians

Danish Medical Society

Danish Society of Emergency Medicine

Danish Society of Hematology

Honors and Awards

ABIM re-certification in internal medicine (95th percentile score), 2018

Select Recent Publications

To view a detailed list of Dr. Hoeg's publications, please click here.


Hoeg RT, Davis J, Jonas BA, Tuscano J, Rosenberg A, Abedi M. A Phase I Stud of Everolimus and Bendamustine in Patients With Relapsed/Refractory Lymphoid Hematologic Malignancies. Clinical Lymphoma, Myeloma and Leukemia. 2020 Feb19;20(7):453-458. doi:10.1016/j.clml.2020.02.006.

Pham B, Hoeg R, Hariharana N, Alvarez K, Rosenberg AS, Jonas BA, Tuscano JM, Abedi M. Treatment with FLAG followed by second allogeneic stem cell transplant for relapsed acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol. 2019;37:15_suppl, e18503-e18503.

Raghavendra M, Hoeg RT, Bottner WA, Agger WA. Management of neutropenic fever during a transition from traditional hematology/oncology service to hospitalist care. WMJ. 2014 Apr;113(2):53-8. 

Hoeg RT, Skau AM, Nørgaard P, Hansen PB. Complete Remission of diffuse large B-Cell Lymphoma After Eradication of Helicobactor Pylori. J of the Danish Medical Association. 2011;173(39):2425-6.

Hoeg RT, Lee JA, Mathiason MA, Rokkones K, Serck SL, Crampton KL, Emmel A, Jumonville AJ, Severson EA, Go RS. Publication outcomes of phase II oncology clinical trials. Am J Clin Oncol. 2009 Jun;32(3):253-7. doi:10.1097/COC.0b013e3181845544.

Hoeg RT, Andersen A, Leinøe EB, Birgens H. Measuring the Impact of a Restrictive Transfusion Guideline in Patients with Acute Myeloid Leukemia. VoxSanguinis. 2013 Jul:105(1):81-4.